Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Jesse Singh Sells 25,000 James Hardie Shares at $28.82

Director Jesse G. Singh filed a Form 4 with the SEC on November 13, 2026, reporting the sale of 25,000 ordinary shares of James Hardie Industries plc on November 11, 2026.

Aakashdeep | 13 November 2026

Phillippe Lord Gifts 7,100 MTH Shares to Charity on Nov 10

Meritage Homes Corporation Chief Executive Officer and Director Phillippe Lord filed a Form 4 with the SEC on November 13, 2026, disclosing a charitable gift of 7,100 shares of MTH Common Stock transacted on November 10, 2026.

Anjali Anand | 13 November 2026

Puhlmann Buys 41,000 CATX Shares in Two-Day Purchase

Markus Puhlmann, Chief Medical Officer of Perspective Therapeutics, Inc., filed a Form 4 on November 13, 2026, disclosing open-market purchases of 41,000 shares of common stock across two transactions on November 11 and November 12, 2026.

Vinay Lochav | 13 November 2026

Medalist Diversified Posts $13.2M Net Income for Nine Months Through September 2026

Medalist Diversified, Inc. filed its quarterly report on Form 10-Q with the SEC on November 13, 2026, covering the three and nine months ended September 30, 2026, disclosing significant gains from property disposals and a major shift in its balance sheet composition.

Nitish Kishor | 13 November 2026

Katapult Holdings Q3 2026: Loss Widens After Merger

Katapult Holdings, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 13, 2026, covering both third-quarter and nine-month results following a significant merger transaction completed during the period.

Shwetambri Chauhan | 13 November 2026

Soren Acquisition Corp. Reports Q3 2026 Net Income of $2.19M

Soren Acquisition Corp. filed its Form 10-Q for the quarter ended September 30, 2026 with the Securities and Exchange Commission on November 13, 2026, reporting financial results for the three and nine months ended September 30, 2026.

Aakashdeep | 13 November 2026

Indaptus Therapeutics Q3 2026: Cash Rises to $26.6M

Indaptus Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 13, 2026, disclosing a significant increase in cash and a sharply reduced operating loss compared to the prior year period.

Shwetambri Chauhan | 13 November 2026

Cineverse Q2 FY2027: Revenue Doubles to $25.96M

Cineverse Corp. filed its quarterly report on Form 10-Q with the SEC on November 13, 2026, covering the fiscal quarter and six months ended September 30, 2026.

Nitish Kishor | 13 November 2026

FRP Holdings Posts Q3 2026 Net Loss of $165 Thousand

FRP Holdings, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission, reporting a net loss attributable to the company of $165 thousand for the third quarter.

Vinay Lochav | 13 November 2026

TuHURA Biosciences Q3 2026 Results: $1.9M Cash, IND Cleared

TuHURA Biosciences, Inc. reported financial results for the third quarter ended September 30, 2026, disclosing cash of $1.9 million, key clinical and regulatory updates, and two new U.S. patents, in a press release filed November 13, 2026.

Manish Choudhary | 13 November 2026
Support

Hi! How can we help you today?

Loading…